Question 1

Who owns APUS?

Accepted Answer

APIMEDS PHARMACEUTICALS US I (APUS) is held by 4 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC as of Q1 2026.

Question 2

Are institutions buying or selling APUS?

Accepted Answer

In Q1 2026, 4 institutions opened or increased positions in APIMEDS PHARMACEUTICALS US I while 2 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on APUS?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for APIMEDS PHARMACEUTICALS US I.

Question 4

How many hedge funds hold APUS?

Accepted Answer

4 institutional investors report holding APIMEDS PHARMACEUTICALS US I (APUS) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into APUS?

Accepted Answer

As of Q1 2026, tracked institutions in APIMEDS PHARMACEUTICALS US I show 4 buyers versus 2 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
VAVANGUARD CAPITAL MANAGEMENT LLC	New	95,929	$171,617	0.0%	-44.62%	35
GEODE CAPITAL MANAGEMENT, LLC	Increased	40,051(+14.8%)	$71,666	0.0%	-59.91%	16
VFVANGUARD FIDUCIARY TRUST CO	New	24,039	$43,006	0.0%	-44.62%	31
UBS Group AG	Increased	4,187(+619.4%)	$7,491	0.0%	-46.56%	18
BANK OF AMERICA CORP /DE/	Exited	0(-100.0%)	$66	0.0%	-25.35%	0
JANE STREET GROUP, LLC	Exited	0(-100.0%)	$44,588	0.0%	-20.73%	0

APIMEDS PHARMACEUTICALS US I

Continue exploring

Other Healthcare stocks held by institutions